Glycogen synthase kinase-3 (GSK-3), which phosphorylates and inactivates glycogen synthase, is elevated in insulin resistant states including individuals with type 2 diabetes independent of obesity [9] and in animal models [10]. Here, INS is linked to obesity disorder.